Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Debt / NOTE 4.500% 7/1
-
Market price (% of par)
-
134.35%
-
Total 13F principal
-
$109,690,000
-
Principal change
-
+$1,483,000
-
Total reported market value
-
$147,492,000
-
Number of holders
-
20
-
Value change
-
+$4,620,806
-
Number of buys
-
9
-
Number of sells
-
14
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q2 2014
As of 30 Jun 2014 MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 had 20 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $109,690,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Citadel Advisors LLC, WOLVERINE ASSET MANAGEMENT LLC, ARISTEIA CAPITAL LLC, Polygon Management Ltd., UBS OCONNOR LLC, AVIVA PLC, LAZARD ASSET MANAGEMENT LLC, TANG CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, and PUTNAM INVESTMENTS LLC.
This table shows 20 bond principal holders of the security as of 30 Jun 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par) |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.